Concepedia

Guofeng Cheng

GC

Statistics

Publications

32

Citations

4.1K

H-Index

23

Active since

1992

Affiliations

Gilead Sciences (United States)(Current)

Scripps Research Institute

Orlando Clinical Research Center

Avail Clinical Research

Seno Medical (United States)

Guofeng Cheng is an author at Gilead Sciences (United States) specializing in viral hepatitis, virology, and molecular virology.

ORCID

Publications per year

1992–2022

32

Publications

32

Robust hepatitis C virus infection <i>in vitro</i>

Jin Zhong, Pablo Gastaminza, Guofeng Cheng et al. · Proceedings of the National Academy of Sciences · 2005 · 1.7K citations

, , +15

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

Pablo Gastaminza, Guofeng Cheng, Stefan Wieland et al. · Journal of Virology · 2007 · 438 citations · Full text

, , +16

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

John O. Link, James G. Taylor, Lianhong Xu et al. · Journal of Medicinal Chemistry · 2013 · 292 citations

, , +17

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost

Jin Zhong, Pablo Gastaminza, Josan Chung et al. · Journal of Virology · 2006 · 245 citations · Full text

, , +17

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C

Eric Lawitz, Daniel Gruener, John M. Hill et al. · Journal of Hepatology · 2012 · 158 citations

, , +11

1–5 of 32